A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2002
12/19/2002	US20020193349 For use in formulation for oral cavity, cosmetics
12/19/2002	US20020193342 Modifying undesirable tastes
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	US20020193322 Adding trisubstituted salt of glycyrrhizic acid to aqueous soltuion of first physiologically acceptable compound of an acidic nature, and second physiologically acceptable compound of a basic nature
12/19/2002	US20020193319 Administering epidermal growth factor (EGF)-isoflavone for preventing development of EGF-receptor expressing cancer
12/19/2002	US20020193311 Novel cytostatic conjugates with integrin ligands
12/19/2002	US20020193297 Recombinant human alpha-fetoprotein as an immunosuppressive agent
12/19/2002	US20020193290 Methods for fine powder formation
12/19/2002	US20020193287 Mixing subunit complex is cardiac troponin IC (cTnIC) solution with an active polymer to form a stabilized cTnIC-polymer conjugate
12/19/2002	US20020192814 Colloidal metal compositions and methods
12/19/2002	US20020192794 Purification of plasmin; obtain sample of plasminogen, incubate with activator, recover plasmin
12/19/2002	US20020192770 Beta-glucan products and extraction processes from cereals
12/19/2002	US20020192683 Fluorescent cobalamins and uses thereof
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192316 Novel chocolate composition as delivery system for nutrients and medications
12/19/2002	US20020192302 Transdermal and topical administration of antidepressant drugs using basic enhancers
12/19/2002	US20020192301 Transdermal and topical administration of antihypertensive agents using basic enhancers
12/19/2002	US20020192300 Transdermal and topical administration of antipsychotic agents using basic enhancers
12/19/2002	US20020192298 Treatment of acne
12/19/2002	US20020192297 Hydrogen peroxide disinfectant with increased activity
12/19/2002	US20020192294 Induced phase transition method for the production of microparticles containing hydrophobic active agents
12/19/2002	US20020192291 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
12/19/2002	US20020192288 Methods and compositions for treating pain of the mucous membrane
12/19/2002	US20020192286 Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
12/19/2002	US20020192285 Controlled release pellet formulation
12/19/2002	US20020192283 Odor-masking coating for a pharmaceutical preparation
12/19/2002	US20020192282 Multilayer pharmaceutical product for release in the colon
12/19/2002	US20020192281 Beta-lactam antibiotic-containing tablet and production thereof
12/19/2002	US20020192280 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
12/19/2002	US20020192279 Method for producing antibiotic composites
12/19/2002	US20020192278 Filler binder for tablets
12/19/2002	US20020192275 Liposome composition for improved intracellular delivery of a therapeutic agent
12/19/2002	US20020192271 Method for causing local hemostasis and hemostatic composition for local hemostasis
12/19/2002	US20020192254 Oil in water emulsion; skin absorption; containing maracalcitol
12/19/2002	US20020192243 Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
12/19/2002	US20020192242 Bone disorders; drug delivery; mixture of bone density regulator and base
12/19/2002	US20020192241 Methods of using kavalactone compositions
12/19/2002	US20020192235 Novel vitamin b12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192222 Receptor specific transepithelial transport of therapeutics
12/19/2002	US20020192211 Method of treating tumor cells by inhibiting growth factor receptor function
12/19/2002	US20020192207 Pharmaceutical compositions of fibrinolytic agent
12/19/2002	US20020192205 Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
12/19/2002	US20020192203 Sterol absorption inhibitor compositions
12/19/2002	US20020192184 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity
12/19/2002	US20020192164 Methods and compositions for the pulmonary delivery insulin
12/19/2002	US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002	DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt
12/19/2002	DE10127712A1 Use of immunoglobulin M for treatment and prevention of systemic lupus erythematosus, administered subcutaneously or intramuscularly
12/19/2002	CA2852202A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2488850A1 Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer
12/19/2002	CA2450316A1 Cd10-activated prodrug compounds
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2450238A1 Oral pharmaceutical composition containing a statin derivative
12/19/2002	CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	CA2449593A1 Spray freeze-dried compositions
12/19/2002	CA2449571A1 Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
12/19/2002	CA2449519A1 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	CA2449517A1 Tissue-specific endothelial membrane proteins
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2447891A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	CA2446223A1 Stabilized dispersion of phytosterol in oil
12/19/2002	CA2446194A1 Taste modifiers comprising a chlorogenic acid
12/18/2002	EP1266657A1 Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride
12/18/2002	EP1266656A1 Anionic exchange polymer complexes of buspirone
12/18/2002	EP1266654A1 Stabilised amlodipine maleate formulations
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266013A2 Heparinase iii and uses thereof
12/18/2002	EP1266009A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF
12/18/2002	EP1265942A2 Use of poly(diallylamine) polymers
12/18/2002	EP1265930A1 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265698A1 Lipid nanocapsules, preparation method and use as medicine
12/18/2002	EP1265683A1 Methods for extraction and reaction using supercritical fluids
12/18/2002	EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
12/18/2002	EP1265639A1 The use of anticoagulant agents in the extracorporeal treatment of blood
12/18/2002	EP1265638A1 Compositions for transdermal and transmucosal administration of therapeutic agents
12/18/2002	EP1265633A2 Adjuvant for vaccines
12/18/2002	EP1265630A2 Use of insulin for the treatment of cartilagenous disorders
12/18/2002	EP1265618A1 Anaesthetic composition
12/18/2002	EP1265617A2 Novel topical oestroprogestational compositions with systemic effect
12/18/2002	EP1265614A1 Novel galenical form for oral administration with prolonged release of molsidomine
12/18/2002	EP1265612A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid
12/18/2002	EP1265608A2 Oxazolidinone tablet formulation
12/18/2002	EP1265598A1 Pharmaceutical composition for application to mucosal surfaces
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs
12/18/2002	EP1265595A2 Stabilized ascorbic acid solutions
12/18/2002	EP1068240B1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
12/18/2002	EP0989847B1 Anti-tumoral therapy agent
12/18/2002	EP0938331B1 Therapeutic uses of bpi protein products in cystic fibrosis patients
12/18/2002	EP0938301B1 Directly compressible lactitol and method
12/18/2002	EP0934078B1 Permeation enhancers for transdermal drug delivery compositions, devices, and methods
12/18/2002	EP0898477B1 Topical administration of premafloxacin for the treatment of systemic bacterial diseases
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0836506B1 Transdermal patch for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/18/2002	EP0804144B1 Solid protector against uv, process for its preparation and use thereof
12/18/2002	EP0788792B1 Matrix type patch preparation

1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 1712